Name: 5th Global Summit on Heart Diseases
Start: 2020-08-20
End: 2020-08-21
Location: Prague, Czech Republic
Rating: 4.6

Heart Diseases Summit 2020 - Heart Diseases Summit 2020

Previous Speakers

Ingolf Schimke

Germany

Prof.Sayed Mohsen Hosseini

Iran

Dr Manikandan Thiruvanath Variam

India

Rita Zilinyi

Hungary

Alexandra Gyongyosi

Hungary

Dr Karunadas Chakkalakal Prabhakaran

India

Dr Ullas Cholayil Sathyabandhu

India

Dr Rudolf Uhliar

Slovakia

Recommended Global Cardiology Conferences

Heart Diseases Summit 2020

About Conference

The Global Summit on Heart Diseases which is to be held in August 20-21, 2020 at Prague, Czech Republic,.Heart Diseases 2020 will be an imaginative and strengthening International get-together reflecting the course of Cardiology in the 21st century in an ensured yet empowering condition that offers a wide extent of redirections to individuals everything considered. This gathering gives an amazing opportunity to discuss the latest enhancements inside the field

Heart Conferences Successfully Organized Past Cardiology Congress on theme Heart Diseases Summit ✦82 Attendees✦54 Speakers ✦5 Exhibitors, Now the series for 2020 Heart Diseases Summit 2020.

Heart Diseases Summit 2020 will accumulate world-class instructors, researchers and cardiologists to talk about procedure for infirmity remediation for Heart, Electrocardiography, Heart Failure, Nuclear Cardiology gatherings, cardiology gatherings are wanted to give differing and stream setting up that will keep accommodating masters by one another of the issues affecting the desire, finding and treatment of cardiovascular pollution. The gathering will be managed around the subject " Accelerated action to prevent the Cardiovascular diseases ".

For what reason to go???

With individuals from around the globe concentrated on finding a few solutions concerning Heart Diseases, this is your single most clear chance to achieve the best aggregation of people from the repairing centers, Universities, pack, and so forth. This Heart Diseases Summit in 2020 will arrange shows up, scatter data, meet with repeating example and potential agents and get name insistence at this 2-day occasion. Comprehensively acclaimed speakers, the latest systems, philosophies, and the most current updates in Cardiology field indicate this gathering.

Target Audience:

Benefits:

Access to all Scientific Sessions (Keynotes, Plenary, Workshops, Symposiums, Poster Presentations)
Get participation certificate from Heart Diseases Summit 2018 Organising Committee Members
You can make contacts with eminent keynote speakers and research professionals for your career growth.
Get 5 star hospitality at the conference venue
B 2 B Meeting with the Companies
Access to all Scientific Sessions (Keynotes, Plenary, Workshops, Symposiums, Poster Presentations)
Full Conference Kit with Conference Souvenir and Final Program (e-copies)
Abstracts will be published in the conference souvenir and respective International journals
Each Abstract will receive unique (DOI) Number provided by Cross Ref
Group Registration benefits

Related Associations and Societies

USA:

Europe:

Asia Pacific:

Sessions/ Tracks

Conference Series llc LTD invites all the participants from all over the world to attend the “Global Summit on Heart Diseases” during April 20-21, 2020 at Kyoto, Japan which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

The Heart Diseases Summit 2020 Emphasis the opportunity to discuss the topics in the sessions, the basic treatments, Diagnosis and Complicated Surgeries of the Cardiology

The Sessions included with the additional topics are the following:

Track 1: Heart Diseases

Heart Di sease is a major cause of disability and premature death throughout the world. The underlying pathology is atherosclerosis, which develops over many years and is usually advanced by the time symptoms occur, generally in middle age. Acute coronary events (heart attacks) and cerebrovascular events (strokes) frequently occur suddenly, and are often fatal before medical care can be given. Heart Conferences promotes awareness against Risk factor modification which reduces clinical events and premature death in people with established cardiovascular disease as well as in those who are at high cardiovascular risk due to one or more risk factors.

Track 2: Heart failure

Heart failure, sometimes known as congestive heart failure, occurs when your heart muscle doesn't pump blood as well as it should. Certain conditions, such as narrowed arteries in your heart (coronary artery disease) or high blood pressure, gradually leave your heart too weak or stiff to fill and pump efficiently. Not all conditions that lead to heart failure can be reversed, but treatments can improve the signs and symptoms of heart failure and help you live longer. Lifestyle changes such as exercising, reducing salt in your diet, managing stress and losing weight can improve your quality of life.

One way to prevent heart failure is to control conditions that cause heart failure, such as coronary artery disease, high blood pressure, diabetes or obesity.

Track 3: Heart Diagnosis & Devices

Medical diagnosis is based on information from sources such as findings from a physical examination, interview with the patient or family or both, medical history of the patient and family, and clinical findings as reported by laboratory tests and radiologic studies. The diagnosis of heart can be carried out by various methods such as by Imaging techniques, Surgeries, electrophysiology, angiography, radiography etc. Medical care is very essential once the heart disease is diagnosed. The aim of treatment are stabilizing the condition, controlling symptoms over the long term, and providing a cure when possible. Stress reduction, diet, and lifestyle changes are key in managing heart disease, but the main stays of conventional care are drugs and surgery.

Heart Devices are electronic devices for assisting cardiac circulation, which is used either to partially or to completely replace the function of a failing heart. The evolution of these wireless cardiac monitoring devices is marking a new era in medicine and a transition from population-level health care to individualized medicine in which suitable patients are equipped with advanced biosensors that, in turn, have their data processed through sophisticated algorithms to predict events before they occur. The pacemaker, defibrillators, biosensors are the heart devices used in treatment of heart diseases.

Track 04: Arrhythmias

An arrhythmia is a problem with the rate or rhythm heartbeat. It means that heart beats too quickly, too slowly, or with an irregular pattern. Many factors can affect heart's rhythm, such as having had a heart attack, smoking, congenital heart defects, and stress. Some substances or medicines may also cause arrhythmias. There are four main types of arrhythmia: extra beats, supraventricular tachycardia, ventricular arrhythmias, and Brady arrhythmias Most arrhythmias can be effectively treated. Treatments may include medications, medical procedures such as a pacemaker, and surgery. Medications for a fast heart rate may include beta blockers or agents that attempt to restore a normal heart rhythm such as procainamide.

Track 05: Cardiovascular Surgeries

Cardiac surgery will be surgery on the heart performed by cardiac surgeons. Every now and again, it is done to treat inconveniences of ischemic coronary illness, amend inherent coronary illness, or treat valvar coronary illness from different causes including endocarditis, rheumatic coronary illness and atherosclerosis. It also includes heart transplantation. The advancement of cardiac surgery and cardiopulmonary bypass techniques has diminished the mortality rates of these surgeries to generally low positions. For instance, repairs of are currently assessed to have 4–6% death rates.

Track 06: Vascular Heart Disease

Vascular heart disease is characterized by damage to or a defect in one of the four heart valves: the mitral, aortic, tricuspid or pulmonary. In vascular heart disease, the valves become too narrow and hardened (stenosis) to open fully, or are unable to close completely (incompetent). Valve disease symptoms can occur suddenly, depending upon how quickly the disease develops. Many of the symptoms are similar to those associated with congestive heart failure, such as shortness of breath and wheezing after limited physical exertion and swelling of the feet, ankles, hands or abdomen (oedema). The severity of vascular heart disease varies. In mild cases there may be no symptoms, while in advanced cases, vascular heart disease may lead to congestive heart failure and other complications. Treatment depends upon the extent of the disease.

Track 07: Cardiac Stroke

The two most normal sorts of stroke are ischaemic and haemorrhagic stroke: Ischaemic strokes happen when the course that provisions blood to your mind is obstructed, for instance by a blood coagulation and haemorrhagic strokes happen when a vein blasts and seeps into your cerebrum, harming cerebrum tissue and keeping some from your cerebrum cells of blood and oxygen. Without a consistent blood supply, your cerebrum cells will be harmed or kick the bucket, which can influence the manner in which your body and mind work.

Transient Ischemic Stroke Attack
Stroke Pathophysiology
Pediatric Strokes
Propelled Treatment for Strokes
Haemorrhagic Strokes

Track 08: Heart and Obesity

People with a body mass index (BMI) of 30 or higher are considered obese. The term obesity is used to describe the health condition of anyone significantly above his or her ideal healthy weight. Obesity increases the risk for heart disease and stroke. But it harms more than just the heart and blood vessel system. It's also a major cause of gallstones, osteoarthritis and respiratory problems. Obesity is intimately intertwined with multiple health conditions that underlie cardiovascular disease including high blood pressure, diabetes, and abnormal blood cholesterol. In addition, weight gain is a frequent consequence of heart-damaging lifestyle choices such as lack of exercise and a fat-laden diet. Obesity also can lead to heart failure. This is a serious condition in which your heart can't pump enough blood to meet your body's needs

Track 09: Myocardial and Pericardial Disease

Damage to the heart muscle most often develops from coronary artery disease (CAD) related myocardial infarction, usually in people in their middle or later decades. Inherited forms of heart muscle disease (Cardiomyopathies) are the most prominent cause of myocardial disease in the young. Myocardial infarction and cardiomyopathies are the major causes of heart failure and arrhythmic sudden death.

Pericardial disease or pericarditis is an inflammation of the pericardium. Pericarditis is characterised by pericardial friction rub (an audible sound of rubbing heard along with the heart beat), chest pain and changes in an electrocardiogram (ECG, test to evaluate the heart function). It is seen more commonly in men than in women. Chronic pericarditis may occur due to the recurrence of acute pericarditis or due to a chronic infection such as tuberculosis.

Track 10: Cardiovascular Diseases and Nutrition

The Cardiovascular diseases affecting the developed world have at their core atherosclerosis and hypertension, both of which are profoundly affected by diet and can be approached, at least in part, from a nutritional point of view, as can the increasing “epidemic” of obesity. Diet is a multi-component mixture of many nutrients, which may interact with one another. The definitive study of nutrients and their impact on cardiovascular disease can be a daunting enterprise. Many dietary risk factors contribute to these diseases in various environmental and ethnic settings. These risk factors are often in evidence in youth so that preventive measures must be initiated early in life.

Track 11: Critical Cardiac Care

Critical cardiac care (CIC) which is also known as coronary care unit (CCU) is a hospital ward specialized in the care of patients with heart attacks, unstable angina, cardiac dysrhythmia and (in practice) various other cardiac conditions that require continuous monitoring and treatment or first aid treatment till the doctor comes. There are also units available in the hospitals to take care of the emergency situation. The Cardiac intensive care unit (CICU) is a specialized ICU dealing with cardiac patients and is usually staffed by cardiologists. It offers critical care staff especially trained in acute coronary syndromes and has additional technology such as intra-aortic balloon pumps, etc.

Track 12: Molecular Cardiology

Molecular cardiology is a new area of cardiovascular medicine that aims to apply molecular biological techniques for the mechanistic investigation, diagnosis, prevention, and treatment of cardiovascular disease. As an emerging discipline, it has changed our conceptual thinking of cardiovascular development, disease etiology, and pathophysiology. Although molecular cardiology is still at a very early stage, it has opened a promising avenue for understanding and controlling cardiovascular disease. A great interest of the laboratory is the identification of novel circulating factors that regulate cardiac biology, including aging and hypertrophy.

Track 13: Hypertension

Hypertension is the single most important risk factor for stroke. It causes about 50 per cent of ischemic strokes and also increases the risk of haemorrhagic stroke. The damage that hypertension causes happens over time and is often only diagnosed when considerable damage has already happened to the body’s blood vessels. The increase in cardiovascular risk has primarily been described in terms of elevated systolic pressure in those over age 60 years and elevation in diastolic pressure in younger individuals.

Track 14: Cardiovascular Toxicology and Pharmacology

Cardiovascular pharmacology focuses on the fundamental mechanisms of cardiovascular cells and how drugs influence the heart and vascular system and those parts of the nervous and endocrine systems that participate in regulating cardiovascular function. Researchers observe the effects of drugs on arterial pressure, blood flow in specific vascular beds, release of physiological mediators, and neural activity arising from system structures.

Cardiovascular toxicology is concerned with the adverse effects of extrinsic and intrinsic stresses on the heart and vascular system. Extrinsic stress involves exposure to therapeutic drugs, natural products, and environmental toxicants. Intrinsic stress refers to exposure to toxic metabolites derived from nontoxic compounds such as those found in food additives and supplements. The intrinsic exposures also include secondary neuro hormonal disturbance such as overproduction of inflammatory cytokines derived from pressure overload of the heart and counter-regulatory responses to hypertension. These toxic exposures result in alterations in biochemical pathways, defects in cellular structure and function, and pathogenesis of the affected cardiovascular system.

Track 15: Cardio-Oncology

Cardio-oncology is the intersection of heart conditions in patients who have been treated for cancer. New insights into how cancer therapies impact cardiovascular homeostasis and long-term effects on cancer survivors. In view of trends, as well as the cardiovascular toxicity potential of radiation and chemotherapy, cancer patients are exposed to cardiovascular morbidity and mortality more than ever before. Anticancer therapies can cause significant injury to the vasculature, resulting in angina, acute coronary syndromes (ACS), stroke, critical limb ischemia, arrhythmias, and heart failure (HF), independently from the direct myocardial or pericardial damage that might occur. Moreover, cancer is generally associated with a hypercoagulable state, which increases the risk of acute thrombotic events.

Track 16: Clinical Cardiology

Cardiology concerns with diseases and disorders of the heart, such as coronary artery disease and congestive heart failure. The field includes medical diagnosis and treatment of congenital heart defects, coronary artery disease, heart failure, vascular heart disease and electrophysiology. Although the heart and circulatory system make up your cardiovascular system. Heart works as a pump that pushes blood to the organs, tissues, and cells of your body. Blood delivers oxygen and nutrients to every cell and removes the carbon dioxide and waste products made by those cells.

Track 17: Cardiac Regeneration

Cardiac Regeneration is a broad effort and comes into existence when the cardiac tissue is damaged and failed to regenerate the myocardium. Where the main principle behind cardiac regeneration is Reparative stem cells have the capability to restore function to damaged tissue by renewing cell growth in cardiac cells destroyed by heart disease. Reparative tools have been engineered to restore damaged heart tissue and function using the body's natural ability to regenerate. Current therapies includes such as adult stem and precursor cells, nuclear dynamics of the heart growth, Reprogramming Fibroblasts to Cardiomyocytes, Stem cells and cell therapy.

Track 18: Cardiac Nursing and Healthcare

Cardiac nursing is a registered nurse who specializes to work with patients who suffer from various conditions of the cardiovascular system. Cardiac nurses help to treat conditions such as unstable angina, cardiomyopathy, coronary artery disease, congestive heart failure, myocardial infarction and cardiac dysrhythmia under the direction of a cardiologist. Cardiac nurses also perform postoperative care on a surgical unit, stress test evaluations, cardiac monitoring, vascular monitoring, and health assessments. Cardiac nurses work in many different environments, including coronary care units (CCU), cardiac catheterization, intensive care units (ICU), operating theatres, cardiac rehabilitation centres, clinical research, cardiac surgery wards, cardiovascular intensive care units (CVICU), and cardiac medical wards.

Track 19: Cardiovascular Engineering

Cardiovascular Engineering stimulates innovative methods and technological advancements in the basic understanding of the cardiovascular system and in cardiovascular diagnosis and treatment applications. Original Contributions outline new concepts and applications in cardiovascular mechanics, cardiology applications and diagnostic methods, cardiac and vascular imaging, devices and instrumentation, hemodynamic monitoring and measurements, cardiac assistance, vascular grafts and artificial hearts, cardiac electrophysiology techniques, computer modeling and drug delivery systems.

Track 20: Nuclear Cardiology & Cardiac CT

Heart disease is the leading cause of death in the western world. Each year in the U.S.A, more than 500,000 men and women die from coronary artery disease. During the past two decades, major strides have been made in the diagnosis and treatment of heart disease. Nuclear Cardiology has played a pivotal role in establishing the diagnosis of heart disease and in the assessment of disease extent and the prediction of outcomes in the setting of coronary artery disease. Nuclear cardiology studies use non-invasive techniques to assess myocardial blood flow, evaluate the pumping function of the heart as well as visualize the size and location of a heart attack. Among the techniques of nuclear cardiology, myocardial perfusion imaging is the most widely used.

A cardiac CT scan is a painless imaging test that uses x rays to take many detailed pictures of your heart and its blood vessels. Different CT scanners are used for different purposes. A multi detector CT is a very fast type of CT scanner that can produce high-quality pictures of the beating heart and can detect calcium or blockages in the coronary arteries. An electron beam CT scanner also can show calcium in coronary arteries. The information obtained can help evaluate whether you are at increased risk for heart attack.

Track 21: Cardiology and Cardiovascular Therapeutics

The Cardiology Conference supports awareness of the treatment of risk factors for heart disease. The most comprehensive provider of cardiovascular services for the prevention, detection, treatment and treatment of cardiovascular diseases. This annual cardiology meeting is a platform for postgraduate education and scientific work in the field of cardiology, angiology, hypertension and cardiac and vascular surgery. Reduces clinical events and premature death in people at risk of cardiovascular disease. Cardiovascular disease is treatable in initial treatment primarily focused on nutrition and lifestyle interventions. The medical meeting focuses on the treatment of diseases and new theories of diagnosis of blood vessels and vascular system or heart.

Track 22: Interventional Cardiology

Interventional cardiology is a branch of cardiology that deals specifically with the catheter based treatment of structural heart diseases.

The principle preferences of utilizing the interventional cardiology or radiology approach are the shirking of the scars and torment, and long post-usable recuperation. Also, interventional cardiology methodology of essential angioplasty is presently the best quality level of consideration for an intense myocardial dead tissue. It includes the extraction of clusters from impeded coronary supply routes and sending of stents and inflatables through a little opening made in a noteworthy vein, which has given it the name "stick gap medical procedure" (instead of "key-gap medical procedure").

Market Analysis | Heart Diseases Summit 2020

Japan's market for medicinal gadgets and materials keeps on being among the world's biggest from couple of years. According to the most recent authority figures from the Ministry of Health, Labor and Welfare (MHLW) and Annual Pharmaceutical Production Statistics, the Japanese market for cardiology therapeutic gadgets and materials in 2017 was around $33.6 billion (up 3.2 percent from 2016 in yen terms). Japan's all out imports of U.S. restorative gadgets were around $7.7 billion of every 2017. In the close term, the market is relied upon to increment because of Japan's maturing populace and proceeded with requests for cutting edge medicinal advances.

The absolute Japanese market for interventional cardiology gadgets is developing at a rate of 1.3%, which will take the 2017 market estimation of ¥151,896 up to ¥166,789 by 2024. Japanese emergency clinics will in general float towards the more costly and mechanically propelled gadgets.

The all out market esteem incorporates an expansive number of sections, for example, the coronary stent, coronary inflatable catheter, expand swelling gadget, interventional coronary catheter, interventional coronary guidewire, introducer sheath, coronary vascular conclusion gadget, symptomatic coronary catheter and guide wire, partial stream hold (FFR) direct wire, intravascular ultrasound (IVUS) catheter, and optical cognizance tomography (OCT) catheter markets.

Cardiology Hospitals at Japan

Tokyo Metropolitan Health & Medical Information Center	Japan Red Cross Hospital (Nihon Sekijyuji Byoin)
International University of Health and Welfare Mita Hospital	National Cardiovascular Center (Kokuritsu Junkankibyo Senta)
Jutendo University Hospital	Osaka Central Hospital (Osaka Chuo Byoin)
Keio University Hospital	Osaka University Hospital (Handai Byoin)
Kanazawa Medical Association	Sumitomo Hospital
Sakakibara Heart Institute	Yodogawa Christian Hospital
St Luke's International Hospital	Nagoya University Hospital
Seibo International Catholic Hospital	Japanese Red Cross Daiichi Hospital
Tokai University Tokyo Hospital	Hokkaido University Hospital
Toranomon Hospital	Hokuto Hospital
University of Tokyo Hospital	Fukuoka University Hospital
Japan Baptist Hospital	Hiroshima University Hospital
Kosei Nenkin Hospital	University of Tsukuba Hospital
Nagasaki University Hospital	Juntendo University Hospital